Alpha Cognition (ACOG) Work In Process (2024 - 2026)
Alpha Cognition (ACOG) posted quarterly Work In Process of $725460.0 for Q4 2025, up 17.94% year-over-year from $615133.0 in Q4 2024, and down 8.5% quarter-over-quarter from $792827.0 in Q1 2025.
Alpha Cognition (ACOG) Work In Process (2024 - 2026) Analysis & Trends
Alpha Cognition's Work In Process history runs 2 years deep, the most recent figure standing at $725460.0 for Q4 2025.
- In Q4 2025, Work In Process rose 17.94% year-over-year to $725460.0; the TTM figure through Dec 2025 stood at $725460.0 (up 17.94% YoY), while the FY2025 annual figure was $725460.0, up 17.94% from the prior year.
- Work In Process for Q4 2025 stood at $725460.0, down from $792827.0 in the prior quarter.
- The five-year high for Work In Process was $792827.0 in Q1 2025, with the low at $615133.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Alpha Cognition | 205.66 Mn | 164.21 Mn | 5.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Mn |
| Dec 31, 2025 | 725,460.00 |
| Mar 31, 2025 | 792,827.00 |
| Dec 31, 2024 | 615,133.00 |